How To Invest In XBiotech Inc Stock - XBIT Share Price Today & News | Stash

Invest in XBiotech Inc on Stash

XBiotech Inc. is a clinical-stage biopharmaceutical company.

To buy fractional shares of XBiotech Inc stock, you'll need to sign up for Stash and open a personal portfolio.

Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share.

Ticker: XBIT

XBiotech Inc

$2.27

-0.87%
(1W)
Jul ’26Jul ’26$3$3$3

$
1W1M1Y5Y

XBIT Performance Breakdown

Share Price
The last publicly stated price for one share of an investment, updated every approximately 20 minutes during market hours (usually business days between 9:30 a.m. and 4:00 p.m. ET).

$2.27

Today's change
This is how much an investment's price has changed over the last day of active trading. For example, if an investment's price was $10 yesterday, and today it rose to $11, you'd see a 1 day change of 10%.

-0.87%

Year to date change (YTD)
This is the performance of the investments since the start of the year, updated approximately every 20 minutes during market hours (usually business days between 9:30 a.m. and 4:00 p.m. ET).

-4.62%

Dividend yield
Some investments pay you profits or interest as you hold them. These payments are called dividends, and this value represents the dollar value as a percentage of the investment's share price.

0.0

Last dividend paid
The dollar value per share that was paid out to shareholders.

N/A

Last dividend pay date
The date shareholders were paid out for the last dividend issued.

N/A

About XBIT

XBiotech Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing True Human monoclonal antibodies for treating a range of different diseases. It focuses on its lead product candidate, Xilonix (MABp1), which is derived from a natural human immune response. The Company has also developed a True Human monoclonal antibody discovery platform and manufacturing system. Xilonix is a therapeutic antibody, which specifically neutralizes interleukin-1 alpha (IL-1a). Its pipeline includes various human antibodies for treating diseases, such as cancer, vascular disease, inflammatory skin disease and diabetes. The Company has completed a Phase III study in Europe for the treatment of symptomatic colorectal cancer. It also investigated its lead product candidate in clinical trials for other inflammatory conditions, including vascular disease, type II diabetes, acne, psoriasis, pyoderma gangrenosum (PG) and hidradenitis suppurativa (HS).

How to buy XBiotech Inc stock on Stash

  1. Enter the amount you'd like to invest in XBiotech Inc stock, then proceed to checkout.
  2. Set up your investment account in just a few minutes.
  3. Once you’ve finished your account, your XBiotech Inc shares will be added to your new portfolio.